FDA Commissioner Sees Industry Role In Regulatory Science Initiative
This article was originally published in The Tan Sheet
Executive Summary
Drug and device firms should have a seat at the table as FDA strengthens its regulatory science program and thus speeds pre-market product reviews, Commissioner Margaret Hamburg says